NCT04998552View on ClinicalTrials.gov

Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 22, 2021

Primary Completion Date

June 22, 2027

Study Completion Date

June 22, 2027

Conditions
Pancreas Adenocarcinoma
Interventions
RADIATION

Cyberknife

5-10 Gy/fraction.Average of 45 minutes every other day for a total of 5 sessions (1.5-2 weeks).

Trial Locations (1)

08534

RECRUITING

Capital Health Medical Center-Hopewell, Pennington

All Listed Sponsors
lead

Capital Health System, Inc

OTHER